COLUMBIA, Md., June 27, 2017 -- WellDoc®, the leading digital health technology company revolutionizing chronic disease management, announced today its support of the American Diabetes Association (ADA) of Maryland’s “The Fabulous YOU!” program. The company is providing the third class of women involved in the program with access to its BlueStar® digital therapeutic for individuals living with type 2 diabetes.
“The Fabulous YOU!” is a year-long program providing fitness and educational classes and materials, cooking classes, and coaching to participants to teach them how to manage their diabetes. Over the past few years, program participants achieved a reduction in their A1C levels and lost up to 16 pounds as they learned integral techniques to manage their diabetes.
“We are happy to be a part of this program to support women living with diabetes that are in our own backyard in the State of Maryland,” said WellDoc’s Director of Clinical Innovation Janice MacLeod. “We feel BlueStar will be another integral tool in each participant’s tool belt to help guide them through the complicated journey of living type 2 diabetes.”
Ms. MacLeod is a Certified Diabetes Educator (CDE) and recently wrote a chapter in the new Nutrition Therapy text and served on the 2017 National Work Group updating the ADA/AADE DSMES National Standards, which were both released at the ADA 77th Scientific Sessions. She was also actively involved on the local board of ADA in Virginia. Ms. MacLeod is the past regional Association of American Diabetes Educators (AADE) president. In her role at WellDoc, she is responsible for partnering with the healthcare team to integrate digital therapeutics, like BlueStar, into clinical practice.
BlueStar is WellDoc’s FDA-cleared, proven digital therapeutic that provides real-time and timely individualized coaching and support, as well as diabetes educational tools that are actionable and personal. WellDoc’s clinical evidence shows a 1.7 to 2.0 point mean A1C reduction for adults living with type 2 diabetes who used BlueStar.
“We are most grateful to WellDoc for providing our ‘Fabulous YOU!’ program participants with BlueStar,” said ADA Maryland’s Area Executive Director David McShea. “WellDoc is a technology leader in the type 2 diabetes space, and we are thrilled to get BlueStar in the hands of each participant in our program’s third cohort.”
To support integration of BlueStar into the program, WellDoc representatives will visit the class and assist participants with the use of BlueStar.
About WellDoc®
WellDoc® is the leading digital health company revolutionizing chronic disease management to help transform lives. Our groundbreaking technology is guiding individuals through the complicated journey of living with chronic diseases, with a goal of improving their health and helping them to be more balanced. We are the first digital health company based on a life science business model, and our foundation is built on randomized clinical trials that demonstrate significant clinical outcomes. We have mastered diabetes management by taking an aggressive and innovative approach that utilizes sophisticated logic and precise algorithms, and integrates the most advanced mobile technology, behavioral insight, and diabetes education for those living with type 2 diabetes. Our FDA-cleared, proven digital therapeutic, BlueStar®, provides real-time and timely individualized coaching and support, as well as diabetes educational tools that are actionable and personal. Our clinical evidence shows a 1.7 to 2.0 point mean A1C reduction for adults living with type 2 diabetes who used BlueStar®. For more information, visit www.WellDoc.com and www.BlueStarDiabetes.com.
About The American Diabetes Association
The American Diabetes Association is leading the fight to Stop Diabetes® and its deadly consequences and fighting for those affected by diabetes. The Association funds research to prevent, cure and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. Founded in 1940, our mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes. For more information please call the American Diabetes Association at 1-800-DIABETES (1-800-342-2383) or visit www.diabetes.org. Information from both these sources is available in English and Spanish.
Contacts: Juliette Bogus PressComm PR Tel: +410.980.5687 Email: [email protected] David McShea, American Diabetes Association, Executive Director Maryland [email protected]


FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Anta Sports Expands Global Footprint With Strategic Puma Stake
Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 



